Advertisement

 

Editors & Advisory Editorial Board

CONTACT US: contact@embomolmed.org

 

Editors
Senior Editors
Advisory Editorial Board
New Board Members Biographies

 

 

Editorial Team

Stefanie Dimmeler (Goethe University, Frankfurt)

editor@embomolmed.org

Stefanie Dimmeler is Professor of Experimental Medicine and Director of the Institute of Cardiovascular Regeneration, Center for Molecular Medicine at the University of Frankfurt, Germany. Her group elucidates the basic mechanisms underlying cardiovascular disease and vessel growth with the aim to develop new cellular and pharmacological therapies for improving the treatment of cardiovascular disease. Her current ongoing research focuses on epigenetic mechanisms that control cardiovascular repair, specifically the function of histone modifying enzymes and microRNAs. She received several international prizes including the Leibniz Award 2005, the Award of the Jung Foundation 2007 and the FEBS award in 2006.

Roberto Buccione (Editor)

r.buccione@embomolmed.org

Roberto Buccione completed his PhD at the University of l'Aquila, Italy studying the process of oogenesis in mammals. After continuing these studies as a post-doctoral researcher at the Jackson Laboratory, Bar Harbor ME, USA, he joined the Mario Negri Sud research institute in S. Maria Imbaro, Italy, where he lead a research group focused on the cell biology of tumour cell invasion. He joined EMBO Molecular Medicine as a Scientific Editor in October 2012.

Céline Carret (Editor)

c.carret@embomolmed.org

Céline Carret completed her PhD at the University of Montpellier, France, characterising host immunodominant antigens to fight babesiosis, a parasitic disease caused by a unicellular Apicomplexan parasite closely related to the malaria agent Plasmodium. She further developed her post-doctoral career on malaria working at the Wellcome Trust Sanger Institute in Cambridge, UK and Instituto de Medicina Molecular in Lisbon, Portugal. Céline joined EMBO Molecular Medicine as a Scientific Editor in March 2011.

Gerlinde Schuster (Editorial Assistant)

contact@embomolmed.org

Gerlinde Schuster joined EMBO in November 2007 and EMBO Molecular Medicine in July 2008.

 

Journal Staff

Jana Christopher - Data Integrity Analyst
Uta Mackensen - Graphics Editor
Sandra Krahl - Graphics Editor

 

Wiley Editorial Staff

Cate Livingstone - Executive Editor, Global Research, Wiley
Georgi Hristov - Assistant Editor, EMBO Press
Rebekka Mindnich - Assistant Editor, EMBO Press
Vivian Killet - Assistant Editor, EMBO Press

 

Senior Editors

Dario Alessi (MRC, Dundee)

d.r.alessi@dundee.ac.uk

Dario Alessi discovered PDK1, a master regulator of insulin-controlled responses and a key anti-cancer agent. His group has also identified a key activatory link between LKB1 and AMPK that impacts on LKB1's activity as tumour-suppressor and as activator for a number of other genes, some of which have been associated with Alzheimer's disease.

Giulio Cossu (Institute of Inflammation and Repair, University of Manchester, Manchester)

giulio.cossu@manchester.ac.uk

Giulio Cossu's interests are in the pathophysiology of muscle development. His group has been working for a number of years on the signals and mechanism that regulate the formation of skeletal muscle during embryonic development and, after birth, when the muscle tissue is damaged as a result of an injury or a primary myopathy.

Uta Francke (Stanford School of Medicine, Stanford)

ufrancke@stanford.edu

Uta Francke's research interests are to understand the functional consequences of microdeletions that cause defined clinical syndromes. Her laboratory has created mouse models for Williams-Beuren syndrome and Prader-Willi syndrome (PWS). The PWS mice are deleted for an imprinted cluster of C/D box small nucleolar RNA (snoRNA) genes. Current goals are to identify the function of these snoRNAs and to understand how their loss causes the PWS phenotype. 

Fred Gage (Salk Institute, San Diego)

gage@salk.edu

Fred Gage concentrates on the adult central nervous system and the plasticity and adaptability to environmental stimulation that remains throughout the life of all mammals. His work may open up the possibility for replacement of brain tissue lost to stroke or Alzheimer's disease and repairing spinal cords damaged by trauma.

Matthias Hentze (EMBL, Heidelberg)

hentze@embl.de

Matthias Hentze's main research interests are the regulation of translation by RNA-binding proteins and microRNAs and the impact that errors in RNA processing and translation have on the ontogeny, progression, diagnosis and therapeutics of human disease. Matthias Hentze is a strong proponent of the concept of "from bench to bedside - and back".

Gökhan S. Hotamışlıgil (Harvard University School of Public Health, Boston)

ghotamis@hsph.harvard.edu

Gökhan Hotamışlıgil is the James S. Simmons Professor of Genetics & Metabolism and Chair of the Department of Genetics & Complex Diseases at the Harvard University School of Public Health. His research centres on the molecular mechanisms of integration between nutrient and pathogen sensing and response pathways in metabolic homeostasis, the metabolic functions of the endoplasmic reticulum, and molecules that govern the biological functions of lipids. Gökhan Hotamışlıgil's contributions have led to the emerging field of "immunometabolism" and produced novel translational avenues against chronic metabolic diseases.

Joan Massagué (Memorial Sloan-Kettering Cancer Center, New York)

j-massague@ski.mskcc.org

Joan Massagué received his Ph.D. degree from the University of Barcelona. He then joined the faculty at the University of Massachusetts Medical School and was later appointed Chair of Cancer Biology, Memorial Sloan-Kettering Cancer Center. He is currently Director of the Sloan-Kettering Institute. His main contributions include the identification of the TGFβ receptors and signal transducers, and the central concept of how this pathway controls cell proliferation and differentiation. Recently, he defined genes and mechanisms for cancer cell dissemination and metastasis. Joan Massagué is an elected member of the U.S. National Academy of Sciences, the Institute of Medicine, and EMBO.

Philippe Sansonetti (Institut Pasteur, Paris)

psanson@pasteur.fr

Philippe Sansonetti's research focusses on dysentery-causing Shigella and on the molecular and cellular basis of Shigella's ability to rupture, invade and cause inflammatory destruction of the intestinal lining. He also is analysing the mechanisms of immunity against Shigella, hoping to use his findings to develop vaccine. 

Bart de Strooper (Dept of Mol. & Dev. Genetics, KU Leuven)

Bart.Destrooper@med.kuleuven.be

Bart de Strooper's research interests are the cell biology of Alzheimer's Disease and Parkinson's Disease. He demonstrated the central role of Presenilin in ?-Secretase processing of Amyloid Precursor Protein and Notch. He received several international prices including the Potamkin Prize in 2002, the Alois Alzheimer Award in 2004 and the Metlife Award in 2008.

EMBO Molecular Medicine
Meyerhofstrasse 1
D-69117 Heidelberg, Germany
Phone: +49 6221 8891 310
Fax: +49 6221 8891 240
info@embomolmed.org

 

Advisory Editorial Board

See the biographies of our newest members

Adriano Aguzzi, Zürich
Kari Alitalo, Helsinki
Russ B. Altman, Stanford
Stylianos Antonarakis, Geneva
Alan Ashworth, London
Karen B. Avraham, Tel Aviv
Andrea Ballabio, Napoli
Yann Barrandon, Lausanne
Anton J. Berns, Amsterdam
Cédric Blanpain, Brussels
Clara D. Bloomfield, Columbus
Pico Caroni, Basel
Vivian Cheung, Philadelphia
Kenneth Chien, Massachusetts
Hans Clevers, Utrecht
Elisabetta Dejana, Milano
Peter Dirks, Toronto
Oliver Eickelberg, Munich
Martin Eilers, Marburg
Marc Feldmann, London
Alain Fischer, Paris
Philippe Froguel, London
Gerardo Gamba, Mexico City
Martin Gleave, Vancouver
Frank G. Grosveld, Rotterdam
Christian Haass, München
Carl-Henrik Heldin, Uppsala
Doug Hilton, Melbourne
Jan Hoeijmakers, Rotterdam
Nancy E. Hynes, Basel
Alain Israel, Paris
Barbara B. Kahn, Boston
Cynthia Kenyon, San Francisco
Robert S. Kerbel, Toronto
Jean-Pierre Kinet, Boston
Jonathan K. C. Knowles, Basel
Andreas E. Kulozik, Heidelberg
Guido Kroemer, Paris
Christopher J. Marshall, London
Anthony P. Monaco, Medford/Somerville
Salvador Moncada, London
Pierluigi Nicotera, Bonn
Bernd Nilius, Leuven
Eric N. Olson, Dallas
Stephen O'Rahilly, Cambridge
Albert Osterhaus, Rotterdam
Manolis Pasparakis, Köln
Christine Petit, Paris
Kornelia Polyak, Boston
Rino Rappuoli, Siena
Peter J. Ratcliffe, Oxford
Gideon Rechavi, Tel Aviv
Paola Ricciardi-Castagnoli, Singapore
Nadia Rosenthal, Monterotondo
Richard Schilsky, Chicago
Nicholas J. Schork, La Jolla
Yosef Shiloh, Ramat Aviv
Gerald Shulman, New Haven
Austin G. Smith, Cambridge
Bruce Spiegelman, Boston
Deepak Srivastava, San Francisco
Giulio Superti-Furga, Vienna
Elaine I. Tuomanen, Memphis
Axel Ullrich, Martinsried
Veronica van Heyningen, Edinburgh
Inder M. Verma, La Jolla
Simon Wain-Hobson, Paris
Gerd Walz, Freiburg
Fiona Watt, London
Christian Weber, München
Lars Zender, Tuebingen